3 unknown. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 3 |
Follow Survival: new trials by email Literature Review of Survival trials Research Report on Survival
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Study of Mitomycin and Lobaplatin in Advanced Colorectal Cancer Patients With Radical Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Mitomycin, Lobaplatin - Colorectal Cancer, Chemotherapy Effect | Phase 2 | Unknown | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 201 | 2022-09-01 | 2022-02-21 |
| Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Paclitaxel, Lobaplatin - Gastric Cancer, Chemotherapy Effect | Phase 2 | Unknown | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 231 | 2021-09-18 | 2022-02-21 |
| Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma MAPI chemotherapy, Apatinib Mesylate, Camrelizumab - Osteosarcoma, Survival | Phase 2 | Unknown | Peking University People's Hospital | 60 | 2020-05-01 | 2020-05-19 |
Neoplasm Metastasis (2) · Colorectal Neoplasms (1) · Drug-Related Side Effects and Adverse Reactions (1) · Osteosarcoma (1) · Stomach Neoplasms (1)
Neoplasms (3) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Neoplasms by Site (2) · Neoplastic Processes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Chemically-Induced Disorders (1) · Colonic Diseases (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Bone Tissue (1)
lobaplatin (2) · Mitomycin (1) · Paclitaxel (1) · apatinib (1) · camrelizumab (1)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (2) · Peking University People's Hospital (1)
China (2)
Kaixiong Tao, Professor (2) · Wei Guo, M.D. (1)
PMID 32306237, PMID 10091726, PMID 11813623, PMID 22287157, PMID 22831982, PMID 25680955, PMID 8156509